Ron Diskin

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 40(Granted Patents)

Location History:

Pasadena, CA (US) (2016 - 2021)
Rehovot, IL (2017 - 2023)

Company Filing History:

10 out of 712

The Rockefeller University

patents

10 out of 4,547

California Institute of Technology

patents

where one patent can have more than one assignee

Years Active: 2016-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12173052 - HIV-1 gp120 CD4 binding site antibodies targeting HIV escape mutants (2024-12-24),

2. 11634478 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof (2023-04-25),

3. 11472868 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 (2022-10-18),

4. 11149081 - HIV-1 GP120 CD4 binding site antibodies targeting HIV escape mutants (2021-10-19),

5. 10889633 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof (2021-01-12),

6. 10590187 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with gp120 (2020-03-17),

7. 9890207 - Highly active agonistic CD4 binding site anti-HIV antibodies (HAADS) comprising modified CDRH2 regions that improve contact with GP120 (2018-02-13),

8. 9879068 - Antibodies targeting HIV escape mutants (2018-01-30),

9. 9783594 - Human immunodeficiency virus neutralizing antibodies and methods of use thereof (2017-10-10),

10. 9493549 - Antibodies directed toward the HIV-1 GP120 CD4 binding site with increased potency and breadth (2016-11-15),

Title: The Innovative Contributions of Ron Diskin

Introduction

Ron Diskin is a prominent inventor based in Pasadena, California, known for his significant contributions to the field of immunology. With a total of 10 patents to his name, Diskin has focused on developing innovative solutions to combat HIV, showcasing his dedication to advancing medical science.

Latest Patents

Among his latest patents, Diskin has developed compositions and methods for anti-HIV broadly neutralizing antibodies that target HIV escape mutants. These antibodies are designed to improve potency and breadth for neutralizing a range of HIV strains. Additionally, he has created broadly neutralizing antibodies directed to epitopes of the Human Immunodeficiency Virus, providing compositions for prophylaxis and methods for diagnosis and treatment of HIV infection.

Career Highlights

Diskin has had a distinguished career, working with esteemed institutions such as The Rockefeller University and the California Institute of Technology. His work has significantly impacted the understanding and treatment of HIV, making him a key figure in the field of biomedical research.

Collaborations

Throughout his career, Diskin has collaborated with notable scientists, including Pamela J. Bjorkman and Michel Nussenzweig. These collaborations have further enriched his research and contributed to the advancement of innovative therapies.

Conclusion

Ron Diskin's work exemplifies the spirit of innovation in the fight against HIV. His patents and collaborations reflect a commitment to improving health outcomes and advancing scientific knowledge.

This text is generated by artificial intelligence and may not be accurate.